Skip to main content

Global Burden of Atopic Dermatitis in Older Adults Is Considerable

Medically reviewed by Carmen Pope, BPharm. Last updated on May 7, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, May 7, 2025 -- The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050, according to a study published online April 1 in Frontiers in Public Health.

Yi Ou, from the First Affiliated Hospital of Chongqing Medical University in China, and colleagues examined the global burden of AD in older adults from 1990 to 2021 and projected change to 2050. Estimates of prevalence, incidence, and disability-adjusted life-years (DALYs) attributable to AD among individuals aged 60 years and older were extracted from the Global Burden of Diseases Study 2021.

The researchers found that the global prevalence of AD in older adults increased from 1990 to 2021 to 11,009,630 cases, even as age-standardized rates decreased, with population growth the main driver. Incidence rates were higher among women and those aged 75 to 79 years. There were positive correlations observed for incidence, prevalence, and DALY rates with sociodemographic index (SDI) levels, while a significant decline was seen in SDI-related inequalities. Increasing incidence, prevalence, and DALY numbers for AD in older adults were anticipated up to 2050, while a decrease was expected in age-standardized DALY rates.

"Globally, AD represented an underestimated public health concern primarily affecting individuals aged 60 and older, with variations observed across genders, age groups, regions, and nations," the authors write. "Consequently, targeted strategies for the effective prevention and management of AD in the older adult are needed to address the impending challenge."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted May 2025

Read this next

Early-Onset Pediatric Atopic Dermatitis Tied to Higher Risk for Uveitis

WEDNESDAY, April 23, 2025 -- Children with early-onset atopic dermatitis (AD) have an elevated risk for pediatric uveitis, according to a study published online April 3 in...

American Academy of Dermatology, March 7 to 11

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted clinicians, academicians, allied health...

AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof

FRIDAY, March 14, 2025 -- Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.